Inventor · disambiguated record
Louis Denis
Also filed as: DENIS LOUIS · DENIS LOUIS J · DENIS LOUIS JEAN
3 granted patents·11 pending applications·11 citations·filing 2004–2024
59Inventor score
Top patents by PatentIndex Score
14 records- 0181US8828391B2Method for EGFR directed combination treatment of non-small cell lung cancerDENIS LOUIS·Filed 2012·Granted Sep 9, 2014·11 cites·16 claims
- 0269US12036224B2Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2023·Granted Jul 16, 2024·0 cites·26 claims
- 0369US2024307398A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientLIBERTAS BIO INC·Filed 2024·Application pending·0 cites
- 0458US2024316046A1Erk1/2 inhibitor combination therapyASANA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 0553US2014341926A1Method for egfr directed combination treatment of cancerDENIS LOUIS·Filed 2014·Application pending·0 cites
- 0652US2017312360A1Method for egfr directed combination treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 0751US2019008868A1Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Application pending·0 cites
- 0849US2023027072A1Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2ASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 0948US2016101175A1Method for egfr directed combination treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1046US10695296B2Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredientASANA BIOSCIENCES LLC·Filed 2018·Granted Jun 30, 2020·0 cites·28 claims
- 1145US2005267140A1Method for treating abnormal cell growthPFIZER·Filed 2005·Application pending·0 cites
- 1240US2005101618A1Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancerPFIZER·Filed 2004·Application pending·0 cites
- 1337US2009082295A1Combinations and methods of using an immunomodulatory oligodeoxynucleotidePFIZER·Filed 2006·Application pending·0 cites
- 1433US2005272755A1Method for treating abnormal cell growthPFIZER·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Louis Denis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →